Falcon Point Capital’s Cardiovascular Systems, Inc. CSII Stock Holding History

Falcon Point Capital’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-8,957	Closed	-$283K	–	68
2020 Q2	$283K	Sell	8,957 -37,780	-81%	-$1.41M	1.39%	30
2020 Q1	$1.65M	Sell	46,737 -10,229	-18%	-$431K	3.57%	4
2019 Q4	$2.77M	Sell	56,966 -103,528	-65%	-$4.71M	3.52%	2
2019 Q3	$7.14M	Buy	160,494 +89	+0.1%	+$4.18K	3.91%	1
2019 Q2	$6.89M	Buy	160,405 +16,577	+12%	+$643K	3.7%	1
2019 Q1	$5.56M	Buy	143,828 +124,676	+651%	+$4.23M	3.03%	5
2018 Q4	$546K	Sell	19,152 -3,960	-17%	-$126K	0.33%	60
2018 Q3	$905K	Buy	23,112 +11,126	+93%	+$411K	0.19%	60
2018 Q2	$388K	Hold	11,986	–	–	0.08%	100
2018 Q1	$263K	Buy	+11,986	New	+$288K	0.05%	105

Other funds holding CSII

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Falcon Point Capital's CSII Position: Q3 2020 in Review

Falcon Point Capital sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2020, closing a stake of 8,957 shares — an estimated $283K sold.

Falcon Point Capital first reported a position in CSII in Q1 2018 and held it in 10 quarters. The position peaked at $7.14M in Q3 2019. 186 funds tracked by Wall St. Rank hold CSII as of Q3 2020.

Falcon Point Capital reported no remaining Cardiovascular Systems, Inc. position as of Q3 2020 after selling out during the quarter.
Falcon Point Capital sold 8,957 Cardiovascular Systems, Inc. shares in Q3 2020, an estimated $283K.
Falcon Point Capital first reported a position in Cardiovascular Systems, Inc. in Q1 2018 and held it in 10 quarters.
Falcon Point Capital's Cardiovascular Systems, Inc. position peaked at $7.14M in Q3 2019.
186 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2020.

Based on Falcon Point Capital's 13F filing for Q3 2020, filed 22 Oct 2020.